7 Current news of Enigma Diagnostics
rss02-08-2010
The Tecan Group and Enigma Diagnostics Limited announced the signing of a manufacturing and supply agreement for Enigma's ML instruments. Under the agreement, Tecan will industrialize and deliver commercially manufactured ML instruments for Enigma's global market supplies for an initial ...
11-30-2009
Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced four senior appointments for its US and European offices. Dr. Jorge Garces will lead the US team as President and CEO with Greg Hamilton, Chief Operating Officer and Chief Financial ...
07-21-2009
Enigma Diagnostics Limited announced that it has signed two patent license agreements with Roche Molecular Systems, Inc. (RMS). The licenses signed on15 July 2009, provide Enigma full access under patents owned or licensed by RMS and its affiliates to practice HybProbe real-time PCR ...
10-27-2008
Enigma Diagnostics Limited announced that it has signed a third licence agreement with Applied Biosystems. The licence provides Enigma with access to claims of US Patent No. 5,928,907 that describe methods for monitoring nucleic acid amplification in real-time. This is the first such licence ...
02-11-2008
Enigma Diagnostics announced that it has signed license agreements with Applera Corporation. The licenses, signed 6 February 2008, include a Real-Time Instrument Patent License Agreement and an Application Kit License Agreement. These agreements provide Enigma with access under patents owned ...
08-24-2007
Enigma Diagnostics announced that it has signed a new exclusive licence agreement with the Defence Science and Technology Laboratory (Dstl). The worldwide licence covers a broad range of technologies, including Pyrostart, ResonSense and Temperature Control, which are important elements of ...
12-22-2006
Enigma Diagnostics, a life sciences company developing rapid molecular diagnostics systems, announced the appointment of Professor Christopher Lowe as Non-executive Director. Professor Lowe is Director of the Institute of Biotechnology at the University of Cambridge. He is a Fellow of the ...
